For example, the albumin-paclitaxel conjugate, primarily used for treating breast cancer, non-small cell lung cancer, and pancreatic cancer [10], has shown therapeutic potential in clinical trials for CRC, suggesting a promising direction for CRC therapy [11]. The gene discussed is ALB; the disease is colorectal carcinoma.